IGFBP1 is a prognostic biomarker in esophageal carcinoma: mechanistic insights from bioinformatics profiling to in vitro functional validation
Huijuan Jiang, Junling Zhu, Zhang Lei, Tuxunayi Yimamu, Hailin Chen, Qiannan Li, Aishanjiang Muhetaer, Ainiwaerjiang Abudourousuli · 2026
Read IGFBP1 is a prognostic biomarker in esophageal carcinoma: mechanistic insights from bioinformatics profiling to in vitro functional validation by Huijuan Jiang, Junling Zhu, Zhang Lei, Tuxunayi Yimamu, Hailin Chen, Qiannan Li, Aishanjiang Muhetaer, Ainiwaerjiang Abudourousuli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624076.txt.
Description
Huijuan Jiang and seven co-authors published a cancer biology study in twenty twenty-six asking whether the protein IGFBP1 can predict outcomes in esophageal carcinoma. The protein is known to promote tumors in several cancers, but its role in this one was unclear. The team mixed large public datasets with laboratory tests on cancer cells.
Cancer Genome Atlas data showed IGFBP1 overexpressed in tumors compared with normal tissue, confirmed by staining of patient samples. High levels tracked with changed immune cell patterns and worse overall and disease-specific survival. Silencing the gene in cell lines suppressed growth, invasion, and migration, supporting IGFBP1 as a prognostic marker and possible treatment target.
Catalog record
| CREATOR | Huijuan Jiang, Junling Zhu, Zhang Lei, Tuxunayi Yimamu, Hailin Chen, Qiannan Li, Aishanjiang Muhetaer, Ainiwaerjiang Abudourousuli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |